Evidence map›Paper›PMID 31075954›Full record

ReviewInternational journal of molecular sciences2019

Anticancer Activity and Underlying Mechanism of Phytochemicals against Multiple Myeloma.

Beomku Kang, Hyunmin Park, Bonglee Kim

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Role of Phytoconstituents in Cancer Treatment: A Review.Recent advances in food, nutrition & agriculture · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Hepatoprotective Potency of Chrysophanol 8-International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Beomku KangCollege of Korean Medicine, Kyung Hee University, Seoul 02453, Korea. beomkukang@khu.ac.kr.
Hyunmin ParkDepartment of Pathology, College of Korean Medicine, Graduate School, Kyung Hee University, Seoul 02453, Korea. rapha837@khu.ac.kr.
Bonglee KimCollege of Korean Medicine, Kyung Hee University, Seoul 02453, Korea. bongleekim@khu.ac.kr.
Kyung Hee University · KR

Funding

the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education NRF-2016R1D1A1B03933656
6 · The paper itself

Abstract

Multiple myeloma (MM)-a common hematologic malignancy of plasma cells-accounts for substantial mortality and morbidity rates. Due to the advent of novel therapies such as immunomodulatory drugs (IMiDs), proteasome inhibitors (PIs), and monoclonal antibodies (mAbs), response rates were increased and free survival and overall survival have been elevated. However, adverse events including toxicity, neuropathy or continuous relapse are still problems. Thus, development of novel drugs which have less side effects and more effective is needed. This review aims to recapitulate the pharmacologic anti-MM mechanisms of various phytochemicals, elucidating their molecular targets. Keywords related to MM and natural products were searched in PUBMED/MEDLINE. Phytochemicals have been reported to display a variety of anti-MM activities, including apoptosis, cell cycle arrest, antiangiogenesis, and miRNA modulation. Some phytochemicals sensitize the conventional therapies such as dexamethasone. Also, there are clinical trials with phytochemicals such as agaricus, curcumin, and Neovastat regarding MM treatment. Taken together, this review elucidated and categorized the evidences that natural products and their bioactive compounds could be potent drugs in treating MM.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisCell Cycle CheckpointsHumansMultiple MyelomaNeovascularization, PathologicPhytochemicalsAntineoplastic Agents, PhytogenicPhytochemicalsangiogenesisanticancerapoptosiscell cycleclinical trialsmiRNAmultiple myelomanatural productsphytochemicals

Identifiers

PMID31075954
PMCPMC6539572
OpenAlexW2944772168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.